Neurotrophic peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8796214
APP PUB NO 20130143809A1
SERIAL NO

13674556

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a neurotrophic peptide having an amino acid sequence of VGDGGLFEKKL (SEQ ID NO:1) and alternatively comprising an adamantyl group at the C- and/or N-terminal end. The neurotrophic peptide can rescue cognition, correct impairments in neural cell proliferation and synaptic plasticity, and thus address the cognitive defects associated with Down syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE RESEARCH FOUNDATION FOR MENTAL HYGIENE INCRIVERVIEW CENTER SUITE 301 150 BROADWAY MENANDS NY 12204

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grundke-Iqbal, Inge Staten Island, US 17 46
Iqbal, Khalid Staten Island, US 21 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00